| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 63.1% | 58.5% | ▼ -4.5% |
| Healthcare Services | 24.1% | 28.1% | ▲ +4.0% |
| Chemicals & Petrochemicals | 3.2% | 2.5% | ▼ -0.8% |
| Industrial Products | 1.3% | 1.8% | ▲ +0.4% |
| Healthcare Equipment & Supplies | 1.2% | 0.9% | ▼ -0.3% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.5% | 58.8% | ▲ +0.3% |
| Healthcare Services | 28.1% | 28.0% | ▼ -0.1% |
| Chemicals & Petrochemicals | 2.5% | 2.8% | ▲ +0.3% |
| Industrial Products | 1.8% | 1.4% | ▼ -0.4% |
| Healthcare Equipment & Supplies | 0.9% | 1.2% | ▲ +0.3% |
Comparing May 2026 → Jun 2026
| # | Stock | Sector | Weight (Jun 2026) |
|---|---|---|---|
| 1 | Vimta Labs Limited ₹5.20 Cr |
Healthcare Services | 0.70% |
| 2 | EQ - LAXMI DENTAL LIMITED ₹1.57 Cr |
Healthcare Equipment & Supplies | 0.21% |
| # | Stock | Sector | Last Weight (May 2026) |
|---|---|---|---|
| 1 | Abbott India Limited ₹3.83 Cr |
Pharmaceuticals & Biotechnology | 0.58% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Cipla Limited ₹24.07 Cr |
Pharmaceuticals & Biotechnology | 0.69% | 3.25% | +2.56% |
| 2 | Max Healthcare Institute Limited ₹31.85 Cr |
Healthcare Services | 2.83% | 4.30% | +1.47% |
| 3 | Zydus Lifesciences Limited ₹16.41 Cr |
Pharmaceuticals & Biotechnology | 1.61% | 2.21% | +0.60% |
| 4 | Granules India Limited ₹13.46 Cr |
Pharmaceuticals & Biotechnology | 1.30% | 1.82% | +0.52% |
| 5 | Corona Remedies Limited ₹18.83 Cr |
Pharmaceuticals & Biotechnology | 2.32% | 2.54% | +0.22% |
| 6 | Aether Industries Limited ₹10.02 Cr |
Chemicals & Petrochemicals | 1.13% | 1.35% | +0.22% |
| 7 | Vijaya Diagnostic Centre Limited ₹11.19 Cr |
Healthcare Services | 1.31% | 1.51% | +0.20% |
| 8 | Anthem Biosciences Limited ₹8.42 Cr |
Pharmaceuticals & Biotechnology | 0.94% | 1.14% | +0.20% |
| 9 | Laurus Labs Limited ₹34.17 Cr |
Pharmaceuticals & Biotechnology | 4.43% | 4.61% | +0.18% |
| 10 | JB Chemicals & Pharmaceuticals Limited ₹51.48 Cr |
Pharmaceuticals & Biotechnology | 6.80% | 6.94% | +0.14% |
| # | Stock | Sector | May 2026 | Jun 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹12.45 Cr |
Pharmaceuticals & Biotechnology | 3.29% | 1.68% | -1.61% |
| 2 | Aster DM Healthcare Limited ₹2.73 Cr |
Healthcare Services | 1.80% | 0.37% | -1.43% |
| 3 | Sun Pharmaceutical Industries Limited ₹64.24 Cr |
Pharmaceuticals & Biotechnology | 9.56% | 8.66% | -0.90% |
| 4 | Strides Pharma Science Limited ₹6.34 Cr |
Pharmaceuticals & Biotechnology | 1.42% | 0.85% | -0.57% |
| 5 | Shaily Engineering Plastics Ltd ₹10.02 Cr |
Industrial Products | 1.75% | 1.35% | -0.40% |
| 6 | Fortis Healthcare Limited ₹26.84 Cr |
Healthcare Services | 3.92% | 3.62% | -0.30% |
| 7 | Apollo Hospitals Enterprise Limited ₹34.06 Cr |
Healthcare Services | 4.83% | 4.59% | -0.24% |
| 8 | Glenmark Pharmaceuticals Limited ₹8.69 Cr |
Pharmaceuticals & Biotechnology | 1.35% | 1.17% | -0.18% |
| 9 | Dr. Lal Path Labs Limited ₹14.35 Cr |
Healthcare Services | 2.11% | 1.94% | -0.17% |
| 10 | Pfizer Limited ₹7.07 Cr |
Pharmaceuticals & Biotechnology | 1.10% | 0.95% | -0.15% |
50 stocks — Jun 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹64.24 Cr |
Pharmaceuticals & Biotechnology |
8.66%
|
|
| 2 |
₹51.48 Cr |
Pharmaceuticals & Biotechnology |
6.94%
|
|
| 3 |
₹34.17 Cr |
Pharmaceuticals & Biotechnology |
4.61%
|
|
| 4 |
₹34.06 Cr |
Healthcare Services |
4.59%
|
|
| 5 |
₹31.85 Cr |
Healthcare Services |
4.30%
|
|
| 6 |
₹26.84 Cr |
Healthcare Services |
3.62%
|
|
| 7 |
₹24.50 Cr |
Healthcare Services |
3.30%
|
|
| 8 |
₹24.07 Cr |
Pharmaceuticals & Biotechnology |
3.25%
|
|
| 9 |
₹23.84 Cr |
Pharmaceuticals & Biotechnology |
3.22%
|
|
| 10 |
₹19.94 Cr |
Pharmaceuticals & Biotechnology |
2.69%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.